3-nitrobenzothiazolo(3,2-a)quinolinium has been researched along with cgp 55845a in 1 studies
| Studies (3-nitrobenzothiazolo(3,2-a)quinolinium) | Trials (3-nitrobenzothiazolo(3,2-a)quinolinium) | Recent Studies (post-2010) (3-nitrobenzothiazolo(3,2-a)quinolinium) | Studies (cgp 55845a) | Trials (cgp 55845a) | Recent Studies (post-2010) (cgp 55845a) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 230 | 0 | 49 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JT; Calver, AR; Collingridge, GL; Davies, CH; Randall, A; Thuault, SJ | 1 |
1 other study(ies) available for 3-nitrobenzothiazolo(3,2-a)quinolinium and cgp 55845a
| Article | Year |
|---|---|
Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit.
Topics: 4-Aminopyridine; Animals; Bicuculline; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Epilepsy; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Gene Deletion; Hippocampus; In Vitro Techniques; Magnesium; Membrane Potentials; Mice; Mice, Knockout; Phosphinic Acids; Potassium Channel Blockers; Propanolamines; Pyramidal Cells; Quinolinium Compounds; Receptors, GABA-B; Time Factors; Valine | 2005 |